VERFAHREN ZUR ERKENNUNG EINER EINZELPERSON DAHINGEHEND, DASS SIE DAS RISIKO DER ENTWICKLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN HAT

European patent · EP3538894 · In force

Register entry

Publication number
EP3538894
Application number
EP17794347
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 9, 2017
Published
Sep 18, 2019
Granted
Sep 2, 2020
Protection ends at the latest
Nov 8, 2037
Next annual fee due
Nov 30, 2026
IPC classes
G01N 33/68 (2006.01)
Priority
EP 16002379 10.11.2016
PCT application
PCT/EP2017/078759 09.11.2017
PCT publication
WO2018/087229 17.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Nov 7, 2020

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 07.11.2020

  6. Sep 2, 2020

    Granted

    Published in Swissreg on 02.09.2020

Parties

Holder

Brain Biomarker Solutions in Gothenburg AB

Erik Dahlbergsgatan 11A, Floor 2, 411 26 Gothenburg, SE

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

BLENNOW, Kaj

43496 Kungsbacka, SE

ZETTERBERG, Henrik

43541 Mölnlycke, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.